STOCK TITAN

PROCEPT BioRobotics (PRCT) director receives new RSU and stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PROCEPT BioRobotics director Thomas M. Prescott received new equity awards in the form of restricted stock units and stock options. He was granted 3,315 restricted stock units, each representing a right to receive one share of Common Stock, and now holds 7,211 shares of Common Stock following the award. The RSUs vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, subject to continued service.

He was also granted stock options for 5,853 shares of Common Stock at an exercise price of $28.78 per share, vesting on the same schedule and expiring on June 8, 2036. These are compensation-related grants rather than open‑market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider PRESCOTT THOMAS M
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 5,853 $0.00 --
Grant/Award Common Stock 3,315 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 5,853 shares (Direct, null); Common Stock — 7,211 shares (Direct, null)
Footnotes (1)
  1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
RSUs granted 3,315 units Restricted stock units granted June 9, 2026
Common shares after RSU grant 7,211 shares Total Common Stock held following non-derivative acquisition
Options granted 5,853 options Stock options granted June 9, 2026
Option exercise price $28.78 per share Conversion or exercise price for 5,853-share option grant
Option expiration June 8, 2036 Expiration date of stock option grant
restricted stock units (RSUs) financial
"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock option (Right to Buy) financial
"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date..."
exercise price financial
"conversion_or_exercise_price": "28.7800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-08T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting financial
"vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PRESCOTT THOMAS M

(Last)(First)(Middle)
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE

(Street)
SAN JOSE CALIFORNIA 95134

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026A(1)3,315A$07,211D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$28.7806/09/2026A5,853 (2)06/08/2036Common Stock5,853$05,853D
Explanation of Responses:
1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Remarks:
/s/ Jonathan Stone, Attorney-in-Fact for Thomas M. Prescott06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Thomas M. Prescott receive from PROCEPT BioRobotics (PRCT)?

Thomas M. Prescott received 3,315 restricted stock units and stock options for 5,853 shares of Common Stock. Both awards were granted as compensation and are not open-market purchases or sales, but equity incentives tied to his continued service as a director.

What is the vesting schedule for the new PRCT restricted stock units and options?

Both the 3,315 restricted stock units and the 5,853-share stock option grant vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, provided Thomas M. Prescott continues his service through the vesting date.

What is the exercise price and expiration date of Thomas M. Prescott’s PRCT stock options?

The newly granted stock options for 5,853 shares of PROCEPT BioRobotics Common Stock have an exercise price of $28.78 per share and expire on June 8, 2036. They represent a right to buy shares at that fixed price once vested.

How many PROCEPT BioRobotics (PRCT) shares does Thomas M. Prescott hold after these grants?

After the grant of 3,315 restricted stock units, Thomas M. Prescott is reported as holding 7,211 shares of PROCEPT BioRobotics Common Stock directly. This figure reflects his position following the reported non-derivative acquisition transaction on June 9, 2026.

Are Thomas M. Prescott’s recent PRCT equity awards open-market purchases or sales?

No, these are not open-market trades. The Form 4 shows an acquisition coded as awards: 3,315 restricted stock units and stock options for 5,853 shares. Such grants are compensation-related equity awards, not discretionary buying or selling in the market.